Your browser doesn't support javascript.
loading
Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
O Murchu, Eamon; Comber, Laura; Jordan, Karen; Hawkshaw, Sarah; Marshall, Liam; O'Neill, Michelle; Ryan, Máirín; Teljeur, Conor; Carnahan, Annasara; Pérez, Jaime Jesús; Robertson, Anna Hayman; Johansen, Kari; Jonge, Jorgen de; Krause, Tyra; Nicolay, Nathalie; Nohynek, Hanna; Pavlopoulou, Ioanna; Pebody, Richard; Penttinen, Pasi; Soler-Soneira, Marta; Wichmann, Ole; Harrington, Patricia.
Afiliação
  • O Murchu E; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Comber L; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Jordan K; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Hawkshaw S; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Marshall L; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • O'Neill M; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Ryan M; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Teljeur C; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Carnahan A; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Health Sciences, Dublin, Ireland.
  • Pérez JJ; Health Information and Quality Authority (HIQA), Dublin, Ireland.
  • Robertson AH; Public Health Agency of Sweden, Solna, Sweden.
  • Johansen K; General Directorate of Public Health and Addictions, IMIB-Arrixaca. Murcia University, Region of Murcia, Spain.
  • Jonge J; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Krause T; European Centre for Disease Prevention and Control, Solna, Sweden.
  • Nicolay N; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Nohynek H; Statens Serum Institut, Copenhagen, Denmark.
  • Pavlopoulou I; European Centre for Disease Prevention and Control, Solna, Sweden.
  • Pebody R; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Penttinen P; Pediatric Research Laboratory, School of Health Sciences, Faculty of Nursing National and Kapodistrian University of Athens, Athens, Greece.
  • Soler-Soneira M; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece.
  • Wichmann O; Institute of Epidemiology & Health, University College London, London, UK.
  • Harrington P; European Centre for Disease Prevention and Control, Solna, Sweden.
Rev Med Virol ; 33(3): e2329, 2023 05.
Article em En | MEDLINE | ID: mdl-35142401
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article